SatO2/FiO2 rate versus PaO2/FiO2 rate for predicting mortality in patients with COVID-19 in a high-altitude hospital

Descripción del Articulo

Objective: To compare the SatO2/FiO2 rate against PaO2/FiO2 rate for predicting mortality in COVID-19 patients in a high altitude hospital. Materials and methods: This is an observational, retrospective, and cross-sectional study, where sensitivity(S), specificity (Sp), positive predictive value (PP...

Descripción completa

Detalles Bibliográficos
Autores: Marmanillo Mendoza, Gabriela, Zuñiga Manrique, Rosario Elsa Jesús, Cornejo Del Valle, Oscar Eduardo, Portilla Canqui, Luis Alberto
Formato: artículo
Fecha de Publicación:2022
Institución:Colegio Médico del Perú
Repositorio:Acta Médica Peruana
Lenguaje:español
OAI Identifier:oai:ojs.pkp.sfu.ca:article/2033
Enlace del recurso:https://amp.cmp.org.pe/index.php/AMP/article/view/2033
Nivel de acceso:acceso abierto
Materia:Covid-19
Hospital Mortality
Precctive Value of Tests
Severity of Illness Index
Oxygen Consumption
id REVCMP_8ba40a028b43e6c47e36941aa7f2053c
oai_identifier_str oai:ojs.pkp.sfu.ca:article/2033
network_acronym_str REVCMP
network_name_str Acta Médica Peruana
repository_id_str .
spelling SatO2/FiO2 rate versus PaO2/FiO2 rate for predicting mortality in patients with COVID-19 in a high-altitude hospitalÍndice SatO2/FiO2 versus PaO2/FiO2 para predecir mortalidad en pacientes con COVID-19 en un hospital de alturaMarmanillo Mendoza, GabrielaZuñiga Manrique, Rosario Elsa JesúsCornejo Del Valle, Oscar EduardoPortilla Canqui, Luis AlbertoCovid-19Hospital MortalityPrecctive Value of TestsSeverity of Illness IndexOxygen ConsumptionObjective: To compare the SatO2/FiO2 rate against PaO2/FiO2 rate for predicting mortality in COVID-19 patients in a high altitude hospital. Materials and methods: This is an observational, retrospective, and cross-sectional study, where sensitivity(S), specificity (Sp), positive predictive value (PPV), and negative predictive value (NPV) for both rates were compared. Results: The average age of COVID-19 patients was 62.2 ± 12.8 years. Three quarters (73.7 %) of all patients were male, most frequent comorbidities were diabetes mellitus (21.6 %), and high blood pressure (27.2 %). On the other hand, average SatO2/FiO2 rate was 234.9 ± 121.9, and PaO2/FiO2 was 169.7 ± 84, and 30.5 % of all patients died. A significant relationship between the aforementioned rates and mortality was evidenced. The cutoff point for SatO2/FiO2 was 114.4, with 43.1 % sensitivity, 91.2 % specificity, 68.3 % positive predictive value, and 78.5 % negative predictive value. The cutoff point for PaO2/FiO2 was 134.2, with 63.1 % sensitivity, 67.6 % specificity, 46.1 % positive predictive value, and 80.7 % negative predictive value. Conclusion: Both rates are predictors for mortality; however, SatO2/FiO2 showed better results with respect to the following parameters: sensitivity, specificity, positive predictive value, and negative predictive value.Objetivo: comparar el índice SatO2/FiO2 versus PaO2/FiO2 para predecir mortalidad en pacientes con COVID-19 en un hospital de altura. Materiales y métodos: estudio observacional, retrospectivo y transversal, donde se compararon la sensibilidad (S), especificidad (E), valor predictivo positivo (VPP) y valor predictivo negativo (VPN) de ambos índices. Resultados: La edad promedio de los pacientes con COVID-19 fue 62.2 ±12.8 años, el 73.7% fueron varones, las comorbilidades de mayor frecuencia fueron la diabetes mellitus (21.6%) y la hipertensión arterial (27.2%). Por otro lado el índice promedio SatO2/FiO2 fue 234.9 ±121.9 y el PaO2/FiO2 fue 169.7 ± 84 y el 30.5% de pacientes falleció. Se evidenció relación significativa entre los índices en mención y la mortalidad. Se obtuvo como puntos de corte 114.4 para SatO2/FiO2, con sensibilidad de 43.1%, especificidad de 91.2%, valor predictivo positivo de 68.3% y valor predictivo negativo de 78.5%, mientras que el punto de corte para PaO2/FiO2 fue 134.2, con sensibilidad de 63.1%, especificidad de 67.6%, valor predictivo positivo de 46.1% y valor predictivo negativo de 80.7%. Conclusión: Ambos índices son predictores de mortalidad, sin embargo el SatO2/FiO2 presentó mejores valores, con respecto a algunos de los criterios de sensibilidad, especificidad, valor predictivo positivo y valor predictivo negativo.Colegio Médico del Perú2022-02-04info:eu-repo/semantics/articleinfo:eu-repo/semantics/publishedVersionapplication/pdfhttps://amp.cmp.org.pe/index.php/AMP/article/view/203310.35663/amp.2021.384.2033ACTA MEDICA PERUANA; Vol 38 No 4 (2021): October - DecemberACTA MEDICA PERUANA; Vol. 38 Núm. 4 (2021): Octubre - Diciembre1728-59171018-8800reponame:Acta Médica Peruanainstname:Colegio Médico del Perúinstacron:CMPspahttps://amp.cmp.org.pe/index.php/AMP/article/view/2033/1421Copyright (c) 2022 ACTA MEDICA PERUANAinfo:eu-repo/semantics/openAccessoai:ojs.pkp.sfu.ca:article/20332023-07-06T05:49:43Z
dc.title.none.fl_str_mv SatO2/FiO2 rate versus PaO2/FiO2 rate for predicting mortality in patients with COVID-19 in a high-altitude hospital
Índice SatO2/FiO2 versus PaO2/FiO2 para predecir mortalidad en pacientes con COVID-19 en un hospital de altura
title SatO2/FiO2 rate versus PaO2/FiO2 rate for predicting mortality in patients with COVID-19 in a high-altitude hospital
spellingShingle SatO2/FiO2 rate versus PaO2/FiO2 rate for predicting mortality in patients with COVID-19 in a high-altitude hospital
Marmanillo Mendoza, Gabriela
Covid-19
Hospital Mortality
Precctive Value of Tests
Severity of Illness Index
Oxygen Consumption
title_short SatO2/FiO2 rate versus PaO2/FiO2 rate for predicting mortality in patients with COVID-19 in a high-altitude hospital
title_full SatO2/FiO2 rate versus PaO2/FiO2 rate for predicting mortality in patients with COVID-19 in a high-altitude hospital
title_fullStr SatO2/FiO2 rate versus PaO2/FiO2 rate for predicting mortality in patients with COVID-19 in a high-altitude hospital
title_full_unstemmed SatO2/FiO2 rate versus PaO2/FiO2 rate for predicting mortality in patients with COVID-19 in a high-altitude hospital
title_sort SatO2/FiO2 rate versus PaO2/FiO2 rate for predicting mortality in patients with COVID-19 in a high-altitude hospital
dc.creator.none.fl_str_mv Marmanillo Mendoza, Gabriela
Zuñiga Manrique, Rosario Elsa Jesús
Cornejo Del Valle, Oscar Eduardo
Portilla Canqui, Luis Alberto
author Marmanillo Mendoza, Gabriela
author_facet Marmanillo Mendoza, Gabriela
Zuñiga Manrique, Rosario Elsa Jesús
Cornejo Del Valle, Oscar Eduardo
Portilla Canqui, Luis Alberto
author_role author
author2 Zuñiga Manrique, Rosario Elsa Jesús
Cornejo Del Valle, Oscar Eduardo
Portilla Canqui, Luis Alberto
author2_role author
author
author
dc.subject.none.fl_str_mv Covid-19
Hospital Mortality
Precctive Value of Tests
Severity of Illness Index
Oxygen Consumption
topic Covid-19
Hospital Mortality
Precctive Value of Tests
Severity of Illness Index
Oxygen Consumption
description Objective: To compare the SatO2/FiO2 rate against PaO2/FiO2 rate for predicting mortality in COVID-19 patients in a high altitude hospital. Materials and methods: This is an observational, retrospective, and cross-sectional study, where sensitivity(S), specificity (Sp), positive predictive value (PPV), and negative predictive value (NPV) for both rates were compared. Results: The average age of COVID-19 patients was 62.2 ± 12.8 years. Three quarters (73.7 %) of all patients were male, most frequent comorbidities were diabetes mellitus (21.6 %), and high blood pressure (27.2 %). On the other hand, average SatO2/FiO2 rate was 234.9 ± 121.9, and PaO2/FiO2 was 169.7 ± 84, and 30.5 % of all patients died. A significant relationship between the aforementioned rates and mortality was evidenced. The cutoff point for SatO2/FiO2 was 114.4, with 43.1 % sensitivity, 91.2 % specificity, 68.3 % positive predictive value, and 78.5 % negative predictive value. The cutoff point for PaO2/FiO2 was 134.2, with 63.1 % sensitivity, 67.6 % specificity, 46.1 % positive predictive value, and 80.7 % negative predictive value. Conclusion: Both rates are predictors for mortality; however, SatO2/FiO2 showed better results with respect to the following parameters: sensitivity, specificity, positive predictive value, and negative predictive value.
publishDate 2022
dc.date.none.fl_str_mv 2022-02-04
dc.type.none.fl_str_mv info:eu-repo/semantics/article
info:eu-repo/semantics/publishedVersion
format article
status_str publishedVersion
dc.identifier.none.fl_str_mv https://amp.cmp.org.pe/index.php/AMP/article/view/2033
10.35663/amp.2021.384.2033
url https://amp.cmp.org.pe/index.php/AMP/article/view/2033
identifier_str_mv 10.35663/amp.2021.384.2033
dc.language.none.fl_str_mv spa
language spa
dc.relation.none.fl_str_mv https://amp.cmp.org.pe/index.php/AMP/article/view/2033/1421
dc.rights.none.fl_str_mv Copyright (c) 2022 ACTA MEDICA PERUANA
info:eu-repo/semantics/openAccess
rights_invalid_str_mv Copyright (c) 2022 ACTA MEDICA PERUANA
eu_rights_str_mv openAccess
dc.format.none.fl_str_mv application/pdf
dc.publisher.none.fl_str_mv Colegio Médico del Perú
publisher.none.fl_str_mv Colegio Médico del Perú
dc.source.none.fl_str_mv ACTA MEDICA PERUANA; Vol 38 No 4 (2021): October - December
ACTA MEDICA PERUANA; Vol. 38 Núm. 4 (2021): Octubre - Diciembre
1728-5917
1018-8800
reponame:Acta Médica Peruana
instname:Colegio Médico del Perú
instacron:CMP
instname_str Colegio Médico del Perú
instacron_str CMP
institution CMP
reponame_str Acta Médica Peruana
collection Acta Médica Peruana
repository.name.fl_str_mv
repository.mail.fl_str_mv
_version_ 1816075110988120064
score 13.949868
Nota importante:
La información contenida en este registro es de entera responsabilidad de la institución que gestiona el repositorio institucional donde esta contenido este documento o set de datos. El CONCYTEC no se hace responsable por los contenidos (publicaciones y/o datos) accesibles a través del Repositorio Nacional Digital de Ciencia, Tecnología e Innovación de Acceso Abierto (ALICIA).